The White House has launched a new website, TrumpRx, which lists dozens of prescription drugs at steeply discounted prices. The site, part of President Trump's efforts to reduce direct-to-consumer drug costs, features deals with over a dozen pharmaceutical companies, including Pfizer and Novo Nordisk.
The discounts offered by TrumpRx are significantly lower than list prices, with some examples showing reductions of up to 83%. For instance, a four-week supply of Wegovy injection pens is listed at $199 for the first two months and $349 after that, compared to a list price of $1,349.02.
While the website claims to offer savings to patients, health experts argue that most people with insurance will still pay higher prices due to co-pays. Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, has urged patients to check TrumpRx before purchasing medication, suggesting it could be a game-changer for those without coverage or with high deductibles.
TrumpRx is part of the president's broader push to reduce pharmaceutical costs. Beyond TrumpRx, he has signed deals with several companies to offer their drugs to Medicaid patients at most-favored-nation prices, and agreed to introduce similar pricing for new drugs introduced in the US.
However, critics argue that these efforts will not significantly impact prices for most Americans, as many people pay out-of-pocket only for medications. Furthermore, pharmaceutical companies have raised list prices of 947 brand-name drugs this January, with some increases exceeding inflation rates.
Despite these concerns, TrumpRx has sparked a stir in the healthcare community, with some experts hailing it as a transformative initiative and others questioning its effectiveness.
The discounts offered by TrumpRx are significantly lower than list prices, with some examples showing reductions of up to 83%. For instance, a four-week supply of Wegovy injection pens is listed at $199 for the first two months and $349 after that, compared to a list price of $1,349.02.
While the website claims to offer savings to patients, health experts argue that most people with insurance will still pay higher prices due to co-pays. Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, has urged patients to check TrumpRx before purchasing medication, suggesting it could be a game-changer for those without coverage or with high deductibles.
TrumpRx is part of the president's broader push to reduce pharmaceutical costs. Beyond TrumpRx, he has signed deals with several companies to offer their drugs to Medicaid patients at most-favored-nation prices, and agreed to introduce similar pricing for new drugs introduced in the US.
However, critics argue that these efforts will not significantly impact prices for most Americans, as many people pay out-of-pocket only for medications. Furthermore, pharmaceutical companies have raised list prices of 947 brand-name drugs this January, with some increases exceeding inflation rates.
Despite these concerns, TrumpRx has sparked a stir in the healthcare community, with some experts hailing it as a transformative initiative and others questioning its effectiveness.
I mean, come on, 947 brand-name drugs going up? That's not even inflation-adjusted, that's just straight-up price gouging 
And now TrumpRx comes along and suddenly we're talking about discounts of up to 83%? It sounds too good to be true, but at the same time... I guess it could really help people who can't afford meds without insurance 
. It's like, we're just putting a Band-Aid on the wound instead of actually addressing the systemic issues.
. We need more initiatives like this that put patients first 
.
It's also worth noting that pharmaceutical companies can just increase prices again whenever they want, so we'll see how long these deals last 
. Maybe this is the start of something bigger? 
.
to me. I mean, who comes up with these discounts? 83% off is crazy talk! 
. The list prices are still going to be super high, and these new discounts aren't gonna make a huge difference.
. Guess you could say it's kinda like trying to solve a puzzle – we're not quite sure how all the pieces fit together yet 
.
I wonder how many people will actually be able to take advantage of these discounts though...I'm sure some folks will still have to pay more out of pocket 
. Like, I get that the list prices are insane, but will most folks even qualify for these discounts after co-pays are factored in? 
Not sure how effective TrumpRx is going to be for most Americans. Maybe it'll help some people without insurance or with high deductibles, but others might not notice a big change... 
.
so I just wanna share my thoughts about this new website launched by the White House. First off, I'm loving the idea of making prescription drugs more affordable for people 
.
. And yeah, because a 4-week supply of Wegovy injection pens costs $1,349.02 at full price... totally not some kind of bait-and-switch to get patients hooked on TrumpRx